E.E.S
- Product NDC
- 80005-152
- 11-digit product format
- 800050152
- Labeler code
- 80005
- Product ID
- 80005-152_ad0b7a24-6fae-4dfd-a308-4fd9c543d7e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin Ethylsuccinate
- Dosage form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Carnegie Pharmaceuticals LLC
- Application
- NDA050207
- Marketing category
- NDA
- Marketing start
- 2025-01-15
- Substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Active strength
- 200 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- E.E.S
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 200 mg/5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 1014KSJ86F |
| Rxcui | 686400, 686405, 863603, 863606 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab | Product name | 3 | 20250717 |
| 3b331500-3b74-bd2b-fede-d46839f2f4d5 | Product name | 6 | 20240313 |
| fdae2630-eae0-4769-abfd-8f33d5b771b4 | Product name | 3 | 20240202 |
| 8c898317-b543-1e4e-254f-84cec2f3f57e | Product name | 2 | 20191002 |
| 64ae94c0-3212-d73a-92da-9e6dd85c6ebe | Product name | 2 | 20180118 |
| edcfa1cf-915f-1a4c-d0aa-508cc66e70d9 | Product name | 2 | 20170816 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 57850177-5927-151f-e1fa-7e2ca47f81e5 | Product name | 1 | 20140508 |
| 8ee71591-1d8f-e24e-242b-bfef131e3168 | Product name | 1 | 20140508 |
| bff5cf99-0f45-fa15-2a76-b160c3c4cc3c | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80005-152-18 | E.E.S | 100 mL in 1 BOTTLE | GRANULE, FOR SUSPENSION | 100 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80005-152-18 | ML - Milliliter | 80005-152 | 0e3f42f1-f109-43d8-969b-33fea3b4a688 | 1 | 2025-03-04 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80005-152 | E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [CARNEGIE PHARMACEUTICALS LLC] | 2 | Current NDC, 1 package rows | 20250226_91479d92-3bf3-4eb3-81bd-8ce4956d4347.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 863603 | E.E.S. 200 MG in 5 mL Oral Suspension | PSN | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863606 | E.E.S. 400 MG Oral Tablet | PSN | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686400 | erythromycin ethylsuccinate 200 MG in 5 mL Oral Suspension | PSN | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686405 | erythromycin ethylsuccinate 400 MG Oral Tablet | PSN | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863603 | erythromycin ethylsuccinate 40 MG/ML Oral Suspension [E.E.S.] | SBD | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863606 | erythromycin ethylsuccinate 400 MG Oral Tablet [E.E.S.] | SBD | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686400 | erythromycin ethylsuccinate 40 MG/ML Oral Suspension | SCD | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686405 | erythromycin ethylsuccinate 400 MG Oral Tablet | SCD | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863603 | E.E.S. 200 MG per 5 ML Oral Suspension | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863603 | E.E.S. 200 Oral Suspension | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863603 | E.E.S. 40 MG/ML Oral Suspension | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863606 | E.E.S. 400 MG Oral Tablet | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686400 | EES 40 MG/ML Oral Suspension | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863603 | EES 40 MG/ML Oral Suspension [E.E.S.] | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686405 | EES 400 MG Oral Tablet | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 863606 | EES 400 MG Oral Tablet [E.E.S.] | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
| 686400 | erythromycin ethylsuccinate 200 MG per 5 ML Oral Suspension | SY | 91479d92-3bf3-4eb3-81bd-8ce4956d4347 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 80005-152-18 | 80005015218 | 100 mL in 1 BOTTLE (80005-152-18) | 100 ml | 2025-01-15 | No | No | Current |